EP Patent

EP2987796A1 — Halogen-substituted boronophthalides for the treatment of infections

Assigned to Anacor Pharmaceuticals LLC · Expires 2016-02-24 · 10y expired

What this patent protects

This invention relates to boronophthalide compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. Said compounds are active against fungi and have properties that allow the compound, when placed in …

USPTO Abstract

This invention relates to boronophthalide compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. Said compounds are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present boronophthalide compounds have physiochemical properties that facilitate penetration of the nail plate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2987796A1
Jurisdiction
EP
Classification
—
Expires
2016-02-24
Drug substance claim
No
Drug product claim
No
Assignee
Anacor Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.